Aurobindo Pharma Limited (BOM:524804)
India · Delayed Price · Currency is INR 1,549.65
-15.00 (-0.96%)
At close: Jul 13, 2026
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 891.43 billion as of July 13, 2026. Its market cap has increased by 39.89% in one year.
Market Cap
891.43B
Enterprise Value
865.90B
Revenue
336.53B
Ranking
n/a
PE Ratio
25.43
Stock Price
1,549.65
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 891.43B, an increase of 9,182.59%. That is a compound annual growth rate of 20.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 891.43B | 29.74% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.66T |
| Lupin | 1.14T |
| Dr. Reddy's Laboratories | 1.04T |
| Abbott India | 576.39B |
| GlaxoSmithKline Pharmaceuticals | 412.59B |
| J. B. Chemicals & Pharmaceuticals | 391.39B |
| Rubicon Research | 231.84B |
| Granules India | 220.43B |